# NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine ...

- URL: https://theranews.net/blog/2026-01-15-nrx-pharmaceuticals-nasdaqnrxp-announces-70000-patient-data-on-real-world-use-of-02cf46/
- Published: 2026-01-15
- Type: Archive summary (AI-assisted summary of third-party reporting)
- Original outlet: postregister
- Original report: https://www.postregister.com/businessreport/technology/nrx-pharmaceuticals-nasdaq-nrxp-announces-70-000-patient-data-on-real-world-use-of-ketamine/article_f6fadda6-c9c1-5211-ba3d-bfab785f38e2.html
- Topics: depression
- Publisher: TheraNews, operated by AdvancedCare USA Inc.
- Notice: Educational content, not medical, legal, billing or financial advice. Cite the original outlet, not this summary.

> NRX-100 (preservative-free ketamine) has been granted Fast Track Designation by FDA for treatment of suicidal ideation in patients with Depression and Bipolar Depression.Real-world evidence, consistent with FDA guidance, is supplied and generated by Osmind using its nationwide electronic medical rec

---
![NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine ...](/uploads/news-images/nrx-pharmaceuticals-nasdaq-nrxp-announces-70-000-20260115110054.png)

---
*Originally reported by postregister. [Read more](https://www.postregister.com/businessreport/technology/nrx-pharmaceuticals-nasdaq-nrxp-announces-70-000-patient-data-on-real-world-use-of-ketamine/article_f6fadda6-c9c1-5211-ba3d-bfab785f38e2.html)*

---

*Source: [https://www.postregister.com/businessreport/technology/nrx-pharmaceuticals-nasdaq-nrxp-announces-70-000-patient-data-on-real-world-use-of-ketamine/article_f6fadda6-c9c1-5211-ba3d-bfab785f38e2.html](https://www.postregister.com/businessreport/technology/nrx-pharmaceuticals-nasdaq-nrxp-announces-70-000-patient-data-on-real-world-use-of-ketamine/article_f6fadda6-c9c1-5211-ba3d-bfab785f38e2.html)*